Roll Call published a commentary today by Nancy Davenport-Ennis of the National Patient Advocate Foundation on the effects of the sequester on cancer care. The op ed states that these ‘cuts are shown to directly impact patients through higher copayments, longer travel times and increased travel expenses, visits to multiple providers and locations for care and services, and delays seeking treatment even as cancer progresses.’ Despite these facts, some have called for even deeper cuts to cancer care as a way to find savings. If the impact on patient care has been devastating and has not resulted in any real cost savings under sequestration, more patients will be turned away from lower cost community-based care if even deeper cuts are enacted. For more information on the impact of the sequester on cancer care, please visit the NPAF web site at www.npaf.org.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsPlant biotechnology global food crisis Sustainability patent BIO Food Health Care Intellectual Property BIO Events BIO Investor Forum renewable fuel standard BIO EVENT agriculture biotechnology Biotechnology Industry Benefits of biotech crops health BIOTECH healthcare biotech industry
- Most Popular
- ALS Awareness Month: 10 Things You Should Know About ALS
- The Real Reason Why Salk Refused to Patent the Polio Vaccine
- Psoriasis Awareness Month: Psoriasis isn’t contagious but awareness is!
- Biotech CEOs Speak Out on JOBS Act Success
- Stopped at the Threshold: A New Study Reports on PTO Patent Examinations in the wake of Mayo and Myriad
Latest VideoChristophe Ramstein, Novasentis Inc. at the 2014 BIO International Convention View All >